{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:45:11Z","timestamp":1785426311524,"version":"3.56.0"},"reference-count":22,"publisher":"Scientific Scholar","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:sec>\n            <jats:title>Background &amp; objectives:<\/jats:title>\n            <jats:p>Globally, there is an effort to eliminate the measles and control rubella as these diseases lead to considerable morbidity and mortality especially among under-five children and are important public health problems. This study was aimed to estimate the seroprevalence of measles, mumps and rubella (MMR) antibodies among children of age 5-10 yr in Chandigarh, north India, to provide evidence on prevalent immunity levels.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This cross-sectional study was conducted in Chandigarh, among 196 randomly selected healthy children (5-10 yr), who received either one or two doses of measles or MMR combination vaccine. Socio-economic background and immunization history were recorded. Blood sample (2 ml) was collected to estimate the MMR IgG antibody titres by using ELISA kits.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Protective seroprevalence of MMR antibodies was 40.8, 75.5 and 86.2 per cent, respectively. The geometric mean titres of MMR IgG antibodies in the study children were 11.3, 50.6 and 54.3 international units (IU)\/ ml, respectively. The proportion of seroprotected children for measles was significantly higher among those who had received two or more doses (46.4%) of measles vaccine compared to those who had received single dose (35.6%) (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001). About 16 per cent of children had received single dose of MMR vaccine. Among these, 71.4 and 100 per cent were seroprotected against mumps and rubella, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interpretation &amp; conclusions:<\/jats:title>\n            <jats:p>A large proportion of children aged 5-10 yr lacked protective immunity against measles (60%); about one-fourth (15-25%) were susceptible to infection with mumps and rubella virus. Mumps vaccination may be considered to be included in National Immunization Schedule for children with periodic serosurveillance.<\/jats:p>\n          <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_1453_17","type":"journal-article","created":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T08:11:27Z","timestamp":1561363887000},"page":"396-403","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["Seroprevalence of measles, mumps &amp; rubella antibodies among 5-10 years old children in north India"],"prefix":"10.25259","volume":"149","author":[{"given":"Madhu","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya Prasad","family":"Tripathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhur","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mini P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramanpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.K.","family":"Ratho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"R1-16-20241212","doi-asserted-by":"crossref","first-page":"e472","DOI":"10.1016\/S2214-109X(18)30537-0","article-title":"Estimates of case-fatality ratios of measles in low-income and middle-income countries: a systematic review and modelling analysis","volume":"7","author":"Portnoy","year":"2019","journal-title":"Lancet Glob Health"},{"key":"R5-16-20241212","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s13312-014-0428-6","article-title":"Introducing combined measles, mumps and rubella vaccine in Chandigarh, India: Issues and concerns","volume":"51","author":"Bhatnagar","year":"2014","journal-title":"Indian Pediatr"},{"key":"R6-16-20241212","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s13312-014-0523-8","article-title":"An outbreak of rubella in a union territory of Northern India","volume":"51","author":"Madhanraj","year":"2014","journal-title":"Indian Pediatr"},{"key":"R8-16-20241212","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s13312-011-0066-1","article-title":"Introduction strategy of a second dose measles containing vaccine in India","volume":"48","author":"Gupta","year":"2011","journal-title":"Indian Pediatr"},{"key":"R10-16-20241212","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4103\/ijpvm.IJPVM_122_17","article-title":"2017 Measles-Rubella vaccination campaign in India","volume":"9","author":"Shrivastava","year":"2018","journal-title":"Int J Prev Med"},{"key":"R11-16-20241212","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s13312-015-0666-2","article-title":"IAP position paper on burden of mumps in India and vaccination strategies","volume":"52","author":"Vashishtha","year":"2015","journal-title":"Indian Pediatr"},{"key":"R12-16-20241212","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/infdis\/jis568","article-title":"Waning antibody levels and avidity: Implications for MMR vaccine-induced protection","volume":"206","author":"Kontio","year":"2012","journal-title":"J Infect Dis"},{"key":"R14-16-20241212","first-page":"302","article-title":"Immune response to second dose of MMR vaccine in Indian children","volume":"134","author":"Gomber","year":"2011","journal-title":"Indian J Med Res"},{"key":"R16-16-20241212","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1016\/j.vaccine.2011.02.087","article-title":"Measles susceptibility in children in Karachi, Pakistan","volume":"29","author":"Sheikh","year":"2011","journal-title":"Vaccine"},{"key":"R17-16-20241212","first-page":"309","article-title":"A comparison study of measles antibody between two doses vaccination at 9, 18 months and single dose at 9 months in children 4-6 years old","volume":"94","author":"Techasena","year":"2011","journal-title":"J Med Assoc Thai"},{"key":"R18-16-20241212","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.4161\/hv.25993","article-title":"Immune response to 1 and 2 dose regimens of measles vaccine in Pakistani children","volume":"9","author":"Hussain","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"R19-16-20241212","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1517\/14656566.4.8.1215","article-title":"IgG avidity to distinguish secondary from primary measles vaccination failures: Prospects for a more effective global measles elimination strategy","volume":"4","author":"Paunio","year":"2003","journal-title":"Expert Opin Pharmacother"},{"key":"R20-16-20241212","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1016\/j.vaccine.2004.02.047","article-title":"Waning immunity and subclinical measles infections in England","volume":"22","author":"Glass","year":"2004","journal-title":"Vaccine"},{"key":"R21-16-20241212","first-page":"415","article-title":"Duration of immunity following immunization with live measles vaccine: 15 years of observation in Zhejiang province, China","volume":"69","author":"Dai","year":"1991","journal-title":"Bull World Health Organ"},{"key":"R22-16-20241212","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1016\/j.vaccine.2012.05.019","article-title":"Waning population immunity to measles in Taiwan","volume":"30","author":"Chen","year":"2012","journal-title":"Vaccine"},{"key":"R23-16-20241212","doi-asserted-by":"crossref","first-page":"516","DOI":"10.26719\/2009.15.3.516","article-title":"Immune response to measles vaccine after mass vaccination in Urmia, Islamic republic of Iran","volume":"15","author":"Yekta","year":"2009","journal-title":"East Mediterr Health J"},{"key":"R24-16-20241212","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1016\/S0264-410X(03)00053-7","article-title":"The effect of measles-mumps-rubella (MMR) immunization on the immune responses of previously immunized primary school children","volume":"21","author":"Rager-Zisman","year":"2003","journal-title":"Vaccine"},{"key":"R25-16-20241212","doi-asserted-by":"crossref","first-page":"e42867","DOI":"10.1371\/journal.pone.0042867","article-title":"Seroprevalence of measles-, mumps- and rubella-specific IgG antibodies in German children and adolescents and predictors for seronegativity","volume":"7","author":"Poethko-M\u00fcller","year":"2012","journal-title":"PLoS One"},{"key":"R26-16-20241212","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/acel.12326","article-title":"How sex and age affect immune responses, susceptibility to infections, and response to vaccination","volume":"14","author":"Giefing-Kr\u00f6ll","year":"2015","journal-title":"Aging Cell"},{"key":"R27-16-20241212","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/trstmh\/tru167","article-title":"Sex-based differences in immune function and responses to vaccination","volume":"109","author":"Klein","year":"2015","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R29-16-20241212","first-page":"134","article-title":"Inequity in childhood immunization between urban and rural areas of Peshawar","volume":"23","author":"Naeem","year":"2011","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"R30-16-20241212","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/eurpub\/cki194","article-title":"Understanding variation in measles-mumps-rubella immunization coverage - A population-based study","volume":"16","author":"Wright","year":"2006","journal-title":"Eur J Public Health"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/02223309-201949030-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T23:01:23Z","timestamp":1751497283000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/seroprevalence-of-measles-mumps-rubella-antibodies-among-5-10-years-old-children-in-north-india\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_1453_17","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}